Variant report
Variant | esv3406593 |
---|---|
Chromosome Location | chr3:46780398-46782324 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr3:46780720-46780724 | Hela-S3 | cervix: | n/a | n/a |
2 | CEBPB | chr3:46780721-46781004 | HepG2 | liver: | n/a | n/a |
3 | POLR2A | chr3:46781581-46781781 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | POLR2A | chr3:46780834-46780914 | H1-hESC | embryonic stem cell: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
PRSS46 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6808374 | chr3:46780424-46780425 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs78175662 | chr3:46780451-46780452 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs9865136 | chr3:46780519-46780520 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs570327654 | chr3:46780525-46780526 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs58973116 | chr3:46780547-46780548 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs190915736 | chr3:46780570-46780571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs567947132 | chr3:46780642-46780643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7652302 | chr3:46780666-46780667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs536697572 | chr3:46780746-46780747 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs377567855 | chr3:46780752-46780753 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs34063354 | chr3:46780761-46780762 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs370888989 | chr3:46780793-46780794 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs554655367 | chr3:46780803-46780804 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs146872469 | chr3:46780837-46780838 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs112867019 | chr3:46780875-46780876 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs539546234 | chr3:46780925-46780926 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs184058439 | chr3:46780932-46780933 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs113219602 | chr3:46780981-46780982 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs188216837 | chr3:46781013-46781014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs562440393 | chr3:46781031-46781032 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs573944188 | chr3:46781065-46781066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs544642065 | chr3:46781093-46781094 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562546598 | chr3:46781105-46781106 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs6809112 | chr3:46781151-46781152 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
25 | rs551481704 | chr3:46781180-46781181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs140736558 | chr3:46781220-46781221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115507051 | chr3:46781221-46781222 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs115394858 | chr3:46781230-46781231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6801048 | chr3:46781237-46781238 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs61333746 | chr3:46781282-46781283 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
31 | rs75876996 | chr3:46781303-46781304 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs568889139 | chr3:46781326-46781327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs192053598 | chr3:46781329-46781330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs182985927 | chr3:46781353-46781354 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs566938934 | chr3:46781367-46781368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs187114057 | chr3:46781392-46781393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191229368 | chr3:46781490-46781491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs574229017 | chr3:46781574-46781575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs113823456 | chr3:46781575-46781576 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs556109714 | chr3:46781576-46781577 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371852123 | chr3:46781606-46781607 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs183516131 | chr3:46781624-46781625 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs545082605 | chr3:46781630-46781631 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs560253998 | chr3:46781649-46781650 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs149192292 | chr3:46781674-46781675 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs544859085 | chr3:46781703-46781704 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs6803880 | chr3:46781717-46781718 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
48 | rs77151660 | chr3:46781769-46781770 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | mRNA abundance |
49 | rs529150020 | chr3:46781781-46781782 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs6803972 | chr3:46781782-46781783 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 20688739 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Cancer | 21183584 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Biliary cancer | 19435499 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Bipolar disorder | 20877625 | CNVD |
Bipolar disorder | 21956041 | CNVD |
Bipolar disorder | 22241247 | CNVD |
Biliary cancer | 18923514 | CNVD |
Breast cancer | 21509527 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 16397240 | CNVD |
Breast cancer | 22032731 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Gastric cancer | 16891809 | CNVD |
Night blindness | 17160897 | CNVD |
Cancer | 17160897 | CNVD |
Breast cancer | 20409316 | CNVD |
Lung cancer | 17297452 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Melanoma | 17363583 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Breast cancer | 22522925 | CNVD |
Recurrent pregnancy loss | 19789632 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:46744000-46792200 | Weak transcription | Right Atrium | heart |
2 | chr3:46769000-46792400 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr3:46779200-46782000 | Weak transcription | Left Ventricle | heart |
4 | chr3:46779400-46795400 | Weak transcription | Spleen | Spleen |
5 | chr3:46779400-46799600 | Weak transcription | Pancreas | Pancrea |
6 | chr3:46779600-46780400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr3:46779800-46792800 | Weak transcription | Thymus | Thymus |
8 | chr3:46780800-46785000 | Weak transcription | Skeletal Muscle Male | skeletal muscle |